The Cytochrome P450 CYP389C16 Contributes to the Cross-Resistance Between Cyflumetofen and Pyridaben in Tetranychus Cinnabarinus (Boisduval).

Kaiyang Feng,Shiyuan Ou,Ping Zhang,Xiang Wen,Li Shi,Yuwei Yang,Yuan Hu,Yichao Zhang,Guangmao Shen,Zhifeng Xu,Lin He
DOI: https://doi.org/10.1002/ps.5564
IF: 4.462
2019-01-01
Pest Management Science
Abstract:BACKGROUND Acaricide resistance is a serious problem in spider mites. Cyflumetofen is a new complex II inhibitor, whereas pyridaben acts at complex I and has been used for decades. Although cross-resistance between cyflumetofen and pyridaben has been observed in Tetranychus cinnabarinus, the specific mechanisms at play have not yet been investigated. RESULTS Investigation into the cross-resistance mechanisms identified five P450s, among which CYP389C16 was evaluated as the most likely candidate conferring cross-resistance. Knockdown of CYP389C16 expression via RNA interference diminished the level of cross-resistance in the cyflumetofen-resistant strain. In addition, recombinant CYP389C16 (40 pmol) effectively metabolized 25.0 +/- 0.7% of cyflumetofen, 39.7 +/- 1.0% of pyridaben, and 69.3 +/- 3.3% of AB-1 (active de-esterified metabolite of cyflumetofen) within 2 h. In addition, hydroxylation metabolite of AB-1 was identified by HPLC-MS/MS. CONCLUSIONS The study reveals that overexpressed CYP389C16 is involved in the cross-resistance between cyflumetofen and pyridaben in T. cinnabarinus. (c) 2019 Society of Chemical Industry
What problem does this paper attempt to address?